By Stephenie Smulligan-Maldanis, Nerac Analyst
Brilliant, white teeth and clear skin: it seems like Americans are in constant pursuit of youth and beauty. Read more
Telemedicine: A Tool for Reducing the Cost of Delivering Medicine
By Roz Sweeney, Ph.D., Nerac Analyst
Originally Published: July 21, 2014
Global economic weakness beginning in 2008, along with an aging population, has intensified the need to reduce healthcare costs. There is a general consensus that the rate of increase in healthcare spending is not sustainable. Since 2009, the annual rate of healthcare spending increases have dropped in the United States; however, it is not clear if this is a temporary phenomenon, or if spending increases will resume to previous levels as the economy improves. Read More
Modest Impact on Personalized Medicine Expected from Recent SCOTUS Rulings
By Roz Sweeney, Ph.D. Nerac Analyst, The recent Supreme Court decision on the Association for Molecular Pathology v. Myriad Genetics case was the culmination of much litigation on the validity of patent protection for the genomic sequences of BRCA1 and BRCA2. Myriad Genetics’ patents on these two genes gave it the exclusive right to offer genetic […]
The Importance of Article Selection for Meeting the MedDev 2.7.1 Rev 3 Requirements
By Donna Mitchell-Magaldi, Nerac Analyst, On March 20, 2010, the revised Guideline; MedDev 2.7.1 Rev 3 Clinical Evaluation: A Guide for Manufacturers and Notified Bodies became a requirement for obtaining and maintaining a CE Mark for all classes of devices marketed in the European Union. An important component of the MedDev 2.7.1 Rev 3 is the […]
The Costs of Regulatory Noncompliance in the Medical Device Industry: Is it Worth the Gamble?
By Donna Mitchell-Magaldi, Nerac Analyst,
The global medical device market was valued at $350 billion dollars in 2012 (Mddonline.com, 2012).
Read more
Cost Reduction Technologies: An Expanding Market for Medical Technology Companies
By Roz Sweeney, Ph.D. Nerac Analyst, Healthcare payers, both in the United States and Europe, have been striving to reduce costs in recent years, and this trend is expected to continue. To address this emphasis on cost-reduction, medical device companies are becoming increasingly interested in the market for technologies that reduce costs to the overall healthcare […]
Clinical Literature Evaluations to Support Medical Device Marketing
By Roz Sweeney, Ph.D. Nerac Analyst,
Comprehensive evaluations of the clinical and technical literature serve a variety of purposes for medical device companies.
Read more
Patent Valuation: Unlocking the Monetary Value of Intellectual Property
Watch the webcast here!
Patent Landscape: Applications in Business and Technical Due Diligence
Watch the webcast here!
As Fast Food Goes Healthy, What Opportunities Await Food Companies?
Analyst Q&A: Shanon Trueman
Fast food chains have been jumping on the healthy food bandwagon with varying success for some time now. Enhancing their menus with foods featuring lower fat, lower cholesterol, and lower sodium, the idea is to bolster sales and invite a new demographic into their restaurants. The anti-obesity drive is also affecting fast food restaurant menus. In 2002, a man sued McDonald’s and other fast food restaurants, claiming that he became obese eating a steady diet of their high-fat foods. The suit was dismissed, but the publicity around it was damaging, contributing to declines in fast food sales for a time.
Restaurants have attempted to add healthier items to their menus in the past, with some hits but a lot of misses, too. McDonald’s low-fat beef burger, the McLean, flopped. Pizza Hut’s addition of lower-fat pizza toppings failed. Then, things started to turn around. For example, Burger King’s grilled chicken sandwich, the BK Broiler (now called the Tendergrill), was more successful.